Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Target-Date · Nuveen / TIAA

Nuveen Lifecycle 2030 Fund Class R6 (TCRIX)

Ticker TCRIX · · Holdings as of May 31, 2026

Expense ratio
0.4%$40/yr per $10k
5-yr return
+6.4%annualized
1-yr return
+14.2%as of Dec 2025
Net assets
$4.5Ball share classes
Holdings
24

Bottom line

Is TCRIX a good fund? The bottom line

TCRIX is the Class R6 share class of Nuveen Lifecycle 2030 Fund, a managed target-date mutual fund from Nuveen / TIAA.

It charges 0.4% — about $40 a year on every $10,000 invested, cheaper than 71% of target-date funds we track.

It returned +14.2% over one year, +6.4% a year over five years, +8.4% a year over ten (as of Dec 31, 2025, per its prospectus).

With $4.5 billion in net assets and 24 holdings, its largest position is Nuveen Core Bond Fund (11.2%) and the top 10 make up 63.1% of the portfolio.

What stands out

  • No front-end sales load

Updated Nov 19, 2026

What TCRIX invests in

The Fund seeks high total return over time through a combination of capital appreciation and income.

The Fund is a fund of funds that invests in Class W, Class R6 or Class I shares of other Nuveen mutual funds and in other investment pools or investment products, including other funds or exchange-traded funds (ETFs) advised by the Funds investment adviser, Nuveen Fund Advisors, LLC (Nuveen Fund Advisors), the Funds sub-adviser, Nuveen Asset Management, LLC (Nuveen Asset Management), or their affiliates (collectively, the Underlying Funds). In general, the Fund is designed for investors who have an approximate target retirement year in mind, and the Funds investments are adjusted from more aggressive to more conservative over time as the Funds target retirement year approaches and for approximately 30 years afterwards. The Fund invests in Underlying Funds according to an asset allocation strategy designed for investors retiring in, or planning to retire within a few years of, 2030 and…

From the fund's prospectus (filed Sep 25, 2026).

TCRIX performance

Average annual total returns
1 yr5 yr10 yr
TCRIX+14.2%+6.4%+8.4%
Target-Date median+15.7%+8.2%+8.9%

Source: Fund prospectus, as of Dec 31, 2025

Full TCRIX performance history →

What TCRIX costs

On a $10,000 investment, TCRIX's 0.4% expense ratio costs about $40 a year. The prospectus estimates $699 in total costs over 10 years (assuming 5% annual returns). The median target-date fund charges 0.59%.

See the full TCRIX fee table →

TCRIX top 10 holdings

#Holding% of fund
1Nuveen Core Bond Fund11.18%
2Nuveen Core Plus Bond Fund8.44%
3Nuveen Large Cap Growth Fund5.94%
4Nuveen Large Cap Value Fund5.63%
5Nuveen Dividend Growth Fund5.63%
6Nuveen Growth Opportunities ETF5.61%
7Nuveen International Opportunities Fund5.58%
8Nuveen Dividend Value Fund5.34%
9Nuveen International Bond Fund4.93%
10Nuveen International Equity Fund4.83%

Source: SEC Form N-PORT, period ended May 31, 2026

The top 10 make up 63.1% of the fund. See all top 25 holdings and asset mix →

Alternatives to TCRIX

More funds like TCRIX →

TCRIX FAQ

What is the expense ratio of TCRIX?
TCRIX's expense ratio is 0.4%, which works out to about $40 a year for every $10,000 invested. The prospectus estimates total costs of $699 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is TCRIX a good investment?
It depends on your goals, but the data points to: no front-end sales load. This is general information, not personalized advice.
What does TCRIX hold?
TCRIX's largest holdings are Nuveen Core Bond Fund (11.2%), Nuveen Core Plus Bond Fund (8.4%), Nuveen Large Cap Growth Fund (5.9%), Nuveen Large Cap Value Fund (5.6%), Nuveen Dividend Growth Fund (5.6%). It holds 24 positions in total as of May 31, 2026 (SEC Form N-PORT).
What is TCRIX's 5-year return?
TCRIX returned +6.4% a year over the five years ending Dec 31, 2025, and +8.4% a year over ten years. Past performance does not guarantee future results.
Does TCRIX have a sales load?
No. TCRIX has no front-end sales charge.
Who manages TCRIX?
TCRIX is offered by Nuveen / TIAA through Tiaa-cref Funds.